Preventing progression in men with mild symptoms of benign prostatic hyperplasia: a potential role for phytotherapy

Abstract

Prevalence of benign prostate hyperplasia (BPH) is increasing with the aging population worldwide. Throughout the 20th century, men with minimally symptomatic BPH were generally advised to defer treatment. Treatment deferral or watchful waiting has always appeared reasonable because mild lower urinary tract symptoms suggestive of bladder outlet obstruction are not bothersome and are often regarded as part of the aging process, progression is usually slow, and symptoms often regress spontaneously. This review examines the evidence of the natural history of BPH, highlighting the group of patients with mild symptoms, the risk factors for progression, and the potential role of phytotherapy in this group of men.

Figures

Figure 1

Outcome of 446 patients with mild symptoms of bladder outlet obstruction (International Prostate Symptom Score [IPSS] < 8) over 4 years. Data from Djavan B et al.